Live from the NIH registry
Studies recruiting near Des Moines right now
Top 25 of 221 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Mission Cancer + Blood - IMMC — Des Moines, Iowa (1.9 mi)
· Sponsor: Hoffmann-La Roche
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
University of Iowa Health Care, Mission Cancer + Blood — Waukee, Iowa (14.5 mi)
· Sponsor: Revolution Medicines, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: Children's Oncology Group
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
UI Health Care Mission Cancer and Blood - Des Moines Clinic — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Des Moines, Iowa (1.9 mi)
· Sponsor: AstraZeneca
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Iowa Diabetes and Endocrinology Research Center /ID# 256750 — West Des Moines, Iowa (5.2 mi)
· Sponsor: AbbVie
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Arterial Disease of Legs, Below-the-knee Obstruction
N/A
Interventional 368 participants sought
Unity Point Health Des Moines — Des Moines, Iowa (1.9 mi)
· Sponsor: Concept Medical Inc.
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — West Des Moines, Iowa (5.2 mi)
· Sponsor: Akero Therapeutics, Inc
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
MercyOne Des Moines Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Medtronic Cardiovascular
Encore PFO Closure Device - The PerFOrm Trial
Patent Foramen Ovale, Cryptogenic Stroke
N/A
Interventional 500 participants sought
Mercy One Iowa Heart Center — West Des Moines, Iowa (5.2 mi)
· Sponsor: Encore Medical Inc.
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Iowa Diabetes and Endocrinology Research Center — West Des Moines, Iowa (5.2 mi)
· Sponsor: Eli Lilly and Company
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Metastatic Castration-resistant Prostatic Neoplasms
Phase 3
Interventional 1,203 participants sought
Mission Cancer Blood — Waukee, Iowa (14.5 mi)
· Sponsor: Janssen Research & Development, LLC
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
COPD
N/A
Interventional 70 participants sought
Central Iowa Hospital Corp - UnityPoint Health — Des Moines, Iowa (1.9 mi)
· Sponsor: Fisher and Paykel Healthcare
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — West Des Moines, Iowa (5.2 mi)
· Sponsor: Medtronic
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Mission Cancer Blood — Waukee, Iowa (14.5 mi)
· Sponsor: Janssen Research & Development, LLC
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Digestive System Neuroendocrine Tumor G2
Phase 2
Interventional 100 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — West Des Moines, Iowa (5.2 mi)
· Sponsor: Medtronic
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network